Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 4:7:68.
doi: 10.3389/fmed.2020.00068. eCollection 2020.

Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm

S Morteza Seyed Jafari  1 , Robert E Hunger  1 , Christoph Schlapbach  1
Affiliations
Review

Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm

S Morteza Seyed Jafari et al. Front Med (Lausanne). .

Abstract

Hidradenitis suppurativa is one of the most distressing dermatological conditions and has a significant negative impact on patients' quality of life. However, the exact pathogenic mechanisms remain incompletely understood and-therefore-efficient therapies are still lacking. The current manuscript focuses on new findings on its pathogenic mechanisms and aims to provide practical therapy recommendations.

Keywords: hidradenitis suppurativa; pathogenesis; pathomechanism; therapy; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical practice recommendations for the treatment of HS, modified from Hunger et al. and Saunte and Jemec (15, 31).
See this image and copyright information in PMC

References

    1. Weber P, Seyed Jafari SM, Yawalkar N, Hunger RE. Apremilast in the treatment of moderate to severe hidradenitis suppurativa: a case series of 9 patients. J Am Acad Dermatol. (2017) 76:1189–91. 10.1016/j.jaad.2017.02.026 - DOI - PubMed
    1. Seyed Jafari SM, Knusel E, Cazzaniga S, Hunger RE. A retrospective cohort study on patients with hidradenitis suppurativa. Dermatology. (2018) 234:71–8. 10.1159/000488344 - DOI - PubMed
    1. Houriet C, Seyed Jafari SM, Thomi R, Schlapbach C, Borradori L, Yawalkar N, et al. Canakinumab for severe hidradenitis suppurativa: preliminary experience in 2 cases. JAMA Dermatol. (2017) 153:1195–7. 10.1001/jamadermatol.2017.2392 - DOI - PubMed
    1. Deckers IE, van der Zee HH, Prens EP. Severe fatigue based on anaemia in patients with hidradenitis suppurativa: report of two cases and a review of the literature. J Eur Acad Dermatol Venereol. (2016) 30:174–5. 10.1111/jdv.12680 - DOI - PubMed
    1. Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa–characteristics and consequences. Clin Exp Dermatol. (1996) 21:419–23. 10.1111/j.1365-2230.1996.tb00145.x - DOI - PubMed